MedPath

Comparing the Pain Experience Between Patients Who Have and Who Have Not Undergone Dermatologic Procedures

Not Applicable
Completed
Conditions
Pain
Interventions
Device: Thermage
Other: Needle Application
Device: VBeam Laser
Device: Ulthera
Registration Number
NCT01285947
Lead Sponsor
Northwestern University
Brief Summary

The purpose of this study is to compare the pain experience of patients who have not had dermatologic procedures (previously "unexposed") using energy devices (lasers, radiofrequency, ultrasound, etc.) with patients who have previously had procedures (previously "exposed") using energy devices. Based on previous clinical encounters, individuals with no prior experience with cosmetic procedures appear to experience more pain. However, no study to date has thoroughly examined this observation. As a result, this study has been designed to find a possible difference in pain perception between previously exposed and unexposed patients undergoing cosmetic procedures using energy devices.

Detailed Description

Twenty subjects will be enrolled in the study: 10 subjects who have had cosmetic procedures in the past and 10 subjects who have not had such procedures. For each subject, pain tolerance in three areas will be assessed: temple, midface/cheek, and abdomen. In two areas of the face (temple and midface/cheek), a small sterile needle will be inserted into the skin along with three applications of the following devices that are FDA approved for use on the face: an ultrasound device (Ulthera), a pulsed dye laser (VBeam), and a radiofrequency (Thermage) device. Additionally, the abdomen will receive three of these four devices in a randomized order: small sterile needle insertion, a pulsed dye laser (VBeam) pulse, and a radiofrequency (Thermage) exposure (the ultrasound device, Ulthera, will not be used on the abdomen because it is currently not FDA approved for this indication). Subjects will then be asked to rate their pain after each application at each individual site using a pain scale. In addition, subjects will complete a questionnaire regarding their pain experiences and other possibly related factors before and after the procedures.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  1. Subjects who have an active skin disease or skin infection in or around the treatment.
  2. Subjects who are unable to understand the protocol or give informed consent.
  3. Subjects with photophobia or who are unable to tolerate the treatments.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non-Naive SubjectsNeedle ApplicationSubjects who have previously undergone energy-based dermatologic procedures in the past.
Naive SubjectsUltheraSubjects who have not previously undergone energy-based dermatologic procedures in the past.
Naive SubjectsVBeam LaserSubjects who have not previously undergone energy-based dermatologic procedures in the past.
Naive SubjectsNeedle ApplicationSubjects who have not previously undergone energy-based dermatologic procedures in the past.
Non-Naive SubjectsUltheraSubjects who have previously undergone energy-based dermatologic procedures in the past.
Naive SubjectsThermageSubjects who have not previously undergone energy-based dermatologic procedures in the past.
Non-Naive SubjectsThermageSubjects who have previously undergone energy-based dermatologic procedures in the past.
Non-Naive SubjectsVBeam LaserSubjects who have previously undergone energy-based dermatologic procedures in the past.
Primary Outcome Measures
NameTimeMethod
Pain Rated by Subjects3 hours for all treatments in one visit

The mean pain scores will be compared between naïve subjects and non-naïve subjects averaged over the anatomical sites: periocular (temple), midface/cheek, and abdomen and over all the different treatments.

Pain scores were recorded along a Visual Analog Scale (VAS) with 0 (no pain- better) to 10 (maximal pain-worst). This is a 10 cm long line in which the subject was asked to draw a line on the scale with 0 (no pain- better) at one end to 10 (maximal pain-worst) at the other end. The drawn line was measured on the 10 cm line using a ruler to obtain the score.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Northwestern University Department of Dermatology

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath